Select Page

South Delhi Pharma, New Delhi, India

TIBSOVO ® (ivosidenib tablets), for oral use.

Under Named Patient Supply, SDP serve you through the quality pharmaceutical products as per your needs. Established in the year 1996. SDP have earned global reputation in the market and has widest range of Anti Cancer medicines in India. To get the best price/cost of medicines in India, Call 9891296838 or Email query@southdelhipharma.com to discuss.

TIBSOVO is a prescription medicine. TIBSOVO is used to treat acute myeloid leukemia (AML).
INDICATIONS AND USAGE
TIBSOVO is an isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for the treatment of adult patients with relapsed or ref
DOSAGE FORMS & STRENGTHS
Tablets: 250 mg
Manufactured By: Agios Pharmaceuticals
Prescribing Information URL: Click Here

South Delhi Pharma can facilitate the supply of “TIBSOVO ® (ivosidenib tablets)” to all locations in India and other part of countries after fulfilling the legal requirement (if applicable). All Anticancer drugs available upon request. To get best price please share your mobile number to receive quotes from South Delhi Pharma.

Category:

Get In Touch

Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.

The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.

Contact Number:
M:+91-9891296838 / P:+91-11- 26532129

Email ID:
info@southdelhipharma.com

9 + 3 =

Ivosidenib, sold under the brand name Tibsovo, is a medication for the treatment of acute myeloid leukemia (AML). It is a small molecule inhibitor of isocitrate dehydrogenase-1 (IDH1), which is mutated in several forms of cancer. The drug is being developed by Agios Pharmaceuticals and is in phase III clinical trials.[when?] The U.S. Food and Drug Administration (FDA) awarded orphan drug designation for acute myeloid leukemia and cholangiocarcinoma.

The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.

In 2018, ivosidenib was approved in the United States for relapsed or refractory acute myeloid leukemia (AML) with an IDH1 mutation and is presently[when?] in a phase III clinical trial for cholangiocarcinoma with an IDH1 mutation.

In 2019, ivosidenib was approved in the United States for newly diagnosed acute myeloid leukemia (AML) with a susceptible IDH1 mutation, as detected by an FDA-approved test, in patients who are at least 75 years old or who have comorbidities that preclude the use of intensive induction chemotherapy.

7 reviews for TIBSOVO ® (ivosidenib tablets), for oral use.

  1. SEO

    I just couldn’t go away your web site before suggesting that I extremely loved the standard information an individual provide for your visitors? Is going to be back incessantly in order to investigate cross-check new posts.

    https://www.blogexpander.com/need-web-marketing-advice-that-works-use-these-tips/

  2. Europa-Road medence szállítás

    I simply wanted to appreciate you once again. I’m not certain the things I might have worked on in the absence of those concepts discussed by you about such a subject. Entirely was a distressing setting for me personally, but taking a look at this specialized tactic you processed the issue made me to cry over gladness. I will be thankful for your service and in addition hope you comprehend what a great job you were undertaking instructing other individuals through your web page. More than likely you have never encountered all of us.

    https://europa-road.eu/hu/medence-szallitas-kedvezo-aron.php

  3. www.jetbluemastercard.com

    I loved as much as you’ll receive carried out right here. The sketch is tasteful, your authored subject matter stylish. nonetheless, you command get bought an nervousness over that you wish be delivering the following. unwell unquestionably come more formerly again since exactly the same nearly very often inside case you shield this increase.

    https://castle-campbell.co.uk/doku.php?id=A_quite_interesting_internet_site_along_with_excellent_short_articles!_m1m4n8f9

  4. Skywestonline

    Normally I don’t read article on blogs, but I wish to say that this write-up very forced me to try and do so! Your writing style has been surprised me. Thanks, very nice article.

    http://ccnyfireapparatus.net/2021/07/27/a-quite-intriguing-site-with-terrific-articles-2/

  5. www bluebird com activate

    Fantastic website. Plenty of useful info here. Im sending it to several friends ans also sharing in delicious. And certainly, thanks for your sweat!

    https://www.big-five-personality-tests.com/node/1242

  6. www.aolmail.com

    You made some nice points there. I did a search on the subject matter and found most people will consent with your site.

    https://bookmarkingworld.review/story.php?title=protect-your-net-experience-and-also-aol-mail-from-predators#discuss

  7. icoshock

    I like this web site its a master peace ! Glad I found this on google .

    https://icoshock.com/top-cryptocurrency-to-invest/

Add a review

Your email address will not be published.